(Q41460841)

1 October 2017

1 reference

title

Management of cutaneous lymphoma (English)

1 reference

1 October 2017

Russell-Jones R

1

1 reference

PubMed ID

9138616

1 October 2017

Spittle MF

series ordinal

2

1 reference

1 October 2017

1 December 1996

1 reference

Best Practice and Research: Clinical Haematology

1 October 2017

1 reference

1 October 2017

9

1 reference

1 October 2017

4

1 reference

1 October 2017

743-767

1 reference

Cutaneous T cell lymphoma with suppressor/cytotoxic (CD8) phenotype: identification of rapidly progressive and chronic subtypes

1 October 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Photopheresis for the treatment of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Diagnostic and prognostic significance of clonal T-cell receptor beta gene rearrangements in lymph nodes of patients with mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

The prognosis of patients with lymphomatoid papulosis associated with malignant lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Primary cutaneous CD30-positive large cell lymphoma: definition of a new type of cutaneous lymphoma with a favorable prognosis. A European Multicenter Study of 47 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Association between incidence of non-Hodgkin's lymphoma and solar ultraviolet radiation in England and Wales

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Histopathologic findings in the clinically uninvolved skin of patients with mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

A phase I trial of alpha-interferon in combination with pentostatin in hematologic malignancies

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Differences in clinical behaviour and immunophenotype between primary cutaneous and primary nodal anaplastic large cell lymphoma of T-cell or null cell phenotype

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Systemic therapy of cutaneous T-cell lymphomas (mycosis fungoides and the Sézary syndrome).

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

bcl-2 protein expression and correlation with the interchromosomal 14;18 translocation in cutaneous lymphomas and pseudolymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Angiocentric T-cell lymphoma of the skin. An aggressive lymphoma distinct from mycosis fungoides.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Cutaneous malignant lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Prognosis and staging of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Phase II study of pentostatin and intermittent high-dose recombinant interferon alfa-2a in advanced mycosis fungoides/Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Regressing atypical histiocytosis: a cutaneous proliferation of atypical neoplastic histiocytes with unexpectedly indolent biologic behavior

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Borrelia burgdorferi-associated cutaneous B cell lymphoma: clinical and immunohistologic characterization of four cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Oral methoxsalen photochemotherapy of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Deleted HTLV-I Provirus in Blood and Cutaneous Lesions of Patients with Mycosis Fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

T-cell receptor gene rearrangement in regressing atypical histiocytosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Therapeutic alternatives in cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Mycosis fungoides and the Sézary syndrome: pathology, staging, and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Mycosis fungoides: management with topical nitrogen mustard

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Prognosis with newly diagnosed mycosis fungoides after total skin electron radiation of 30 or 35 GY

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Epidemiology and clinical manifestations of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Phase II trial of intermittent high-dose recombinant interferon alfa-2a in mycosis fungoides and the Sézary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Interferon alfa-2a combined with phototherapy in the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Methotrexate in lymphomatoid papulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Primary cutaneous immunocytoma. A B-cell lymphoma that can easily be mistaken for cutaneous lymphoid hyperplasia.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

1 reference

7 January 2021

Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Complete remissions in psoralen and UV-A (PUVA)-refractory mycosis fungoides-type cutaneous T-cell lymphoma with combined interferon alfa and PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Clinical and pathological heterogeneity in cutaneous gamma-delta T-cell lymphoma: a report of three cases and a review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

A case of cutaneous B-cell lymphoma treated successfully with MACOP-B

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Immunoglobulin gene analysis of cutaneous pseudolymphoma by polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Non-Hodgkin's lymphoma and solar ultraviolet radiation. Data are inconsistent

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Interferon alfa-2a in the treatment of cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Extracorporeal photochemotherapy in the treatment of cutaneous T-cell lymphoma. Complexity of objective evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Radiotherapy of cutaneous B cell lymphomas: our experience in 31 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Ointment-based mechlorethamine treatment for mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Topical mechlorethamine therapy for early stage mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Cutaneous immunocytomas: a clinicopathologic study of 26 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Photochemotherapy alone or combined with interferon alpha-2a in the treatment of cutaneous T-cell lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Chemotherapy for mycosis fungoides and the Sézary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

The treatment of mycosis fungoides with PUVA

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Primary cutaneous B-cell lymphoma: a unique type of low-grade lymphoma. Clinicopathologic and immunologic study of 83 cases.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Histologic assessment of lymph nodes in mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma): clinical correlations and prognostic import of a new classification system

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

MALT and SALT: the clue to cutaneous B-cell lymphoproliferative disease

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Cutaneous B-cell lymphoproliferative diseases: a centenary celebration classification.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

HTLV-1-negative pleomorphic T-cell lymphoma of the skin: the clinicopathological correlations and natural history of 15 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Mechlorethamine hydrochloride solutions and ointment. Prolonged stability and biological activity

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Mucha-Habermann's disease simulating lymphoma cutis. Report of two cases

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Long-term efficacy, curative potential, and carcinogenicity of topical mechlorethamine chemotherapy in cutaneous T cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Methotrexate is effective therapy for lymphomatoid papulosis and other primary cutaneous CD30-positive lymphoproliferative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Mycosis fungoides in the United States. Increasing incidence and descriptive epidemiology

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Detection of clonal T-cell receptor gene rearrangements in the peripheral blood of patients with mycosis fungoides/Sezary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

HTLV-1 provirus and mycosis fungoides

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Analysis of beta, gamma, and delta T-cell receptor genes in mycosis fungoides and Sezary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Analysis of beta, gamma, and delta T-cell receptor genes in lymphomatoid papulosis: cellular basis of two distinct histologic subsets

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

HTLV-1-associated cutaneous disease: a clinicopathological and molecular study of patients from the U.K.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Sézary syndrome: diagnosis, prognosis, and critical review of treatment options

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

New concepts in the classification of cutaneous lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Spectrum of primary cutaneous CD30 (Ki-1)-positive lymphoproliferative disorders. A proposal for classification and guidelines for management and treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

The clinical and histological spectrum of lymphomatoid papulosis

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Primary cutaneous large cell lymphomas of follicular center cell origin. A clinical follow-up study of nineteen patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Classification of primary cutaneous T-cell lymphomas

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Classification of primary cutaneous lymphomas. Historical overview and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Are most primary cutaneous B-cell lymphomas 'marginal cell lymphomas'?

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

1 reference

7 January 2021

Topical carmustine (BCNU) for cutaneous T cell lymphoma: a 15-year experience in 143 patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Low-dose methotrexate to treat erythrodermic cutaneous T-cell lymphoma: results in twenty-nine patients

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Complete remission of a primary cutaneous B cell lymphoma treated with intralesional recombinant interferon alpha-2a

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

Extracorporeal photopheresis for the treatment of cutaneous T-cell lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0950-3536%2896%2980052-7

7 January 2021

10.1016/S0950-3536(96)80052-7

Identifiers

DOI

1 reference

1 October 2017

1 reference

PubMed ID

9138616